Rodolfo Saccoman

Currently building CryptoLeague™ in Wynwood, Miami. Serial Tech Entrepreneur: 2/3 exits | Miami Tech OG | Inventor | @cornell Alum | MBA @ UoM | Avid Investor | Launching Global Co’s | Blockchain, crypto, DeFi, NFT, gaming focused.

Rodolfo is a Brazilian-American seasoned serial entrepreneur known for productizing complex technologies intoglobally recognized companies. Rodolfo came to the US at age 17 and graduated with honors from Cornell University in 1999. Upon graduation Rodolfo led and catapulted innovation and e-commerce at The Breakers in Palm Beach. He became the youngest member of the “investment committee” identifying early investments such as Facebook, Microsoft, and Google. Rodolfo’s 20-year calling for trading began at Cornell, leading him to become a registered broker and portfolio manager at Morgan Stanley; to identify/buy his first crypto currency in 2012; and to begin investing in Altcoins in 2015.

Rodolfo is a serial entrepreneur whose first company, an AI-powered cognitive-behavior-therapy journaling platform, MyTherapyJournal was on the first season of ABC’s “Shark Tank” (Episode 105) in 2009. Then in 2014, Rodolfo founded AdMobilize, which became the world’s #1 trusted leader in anonymous edge-AI audience measurement for the $44B out-of-home (OOH) media advertising and digital signage intelligence. The company grew to 200 clients in over 80 countries, with over 15 billion anonymous AI engagements measured. Rodolfo is an inventor, devising a patent portfolio which was independently valued at $100M. Rodolfo also founded MATRIX Labs, which democratized IoT creation by converging AI with the exponential global developer community. In early 2021, AdMobilize and MATRIX Labs were fully acquired. Over the last decade, Rodolfo has been bullish on the potential of the Miami tech ecosystem.

He has an MBA from the University of Miami, and launched all previous companies from Miami. Rodolfo has proven his ability to turn his disruptive ideas into global companies by leading diverse teams.